메뉴 건너뛰기




Volumn 17, Issue 8, 2012, Pages 797-809

The flavonolignan silibinin potentiates TRAIL-induced apoptosis in human colon adenocarcinoma and in derived TRAIL-resistant metastatic cells

Author keywords

Apoptosis; Colorectal cancer; Flavonoids; Silibinin; TRAIL

Indexed keywords

CASPASE 3; CASPASE 8; CASPASE 9; COMPLEMENTARY DNA; DEATH RECEPTOR 4; DEATH RECEPTOR 5; EMBELIN; PROTEIN MCL 1; RECOMBINANT PROTEIN; RNA; SILIBININ; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; X LINKED INHIBITOR OF APOPTOSIS;

EID: 84865110141     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-012-0731-4     Document Type: Article
Times cited : (41)

References (52)
  • 2
    • 76049128595 scopus 로고    scopus 로고
    • Estimates of cancer incidence and mortality in Europe in 2008
    • doi:10.1016/j.ejca.2009.12.014
    • Ferlay J, Parkin DM, Steliarova-Foucher E (2010) Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 46:765-781. doi:10.1016/j.ejca.2009.12.014
    • (2010) Eur J Cancer , vol.46 , pp. 765-781
    • Ferlay, J.1    Parkin, D.M.2    Steliarova-Foucher, E.3
  • 3
    • 79956124273 scopus 로고    scopus 로고
    • Optimal management of metastatic colorectal cancer: Current status
    • doi: 10.2165/11591770-000000000-00000
    • McRee AJ, Goldberg RM (2011) Optimal management of metastatic colorectal cancer: current status. Drugs 71:869-884. doi: 10.2165/11591770-000000000-00000
    • (2011) Drugs , vol.71 , pp. 869-884
    • McRee, A.J.1    Goldberg, R.M.2
  • 4
    • 79961003508 scopus 로고    scopus 로고
    • Treatment of metastatic colorectal cancer
    • doi:10.1053/j.seminoncol.2011. 05.009
    • Davies JM, Goldberg RM (2011) Treatment of metastatic colorectal cancer. Semin Oncol 38:552-560. doi:10.1053/j.seminoncol.2011. 05.009
    • (2011) Semin Oncol , vol.38 , pp. 552-560
    • Davies, J.M.1    Goldberg, R.M.2
  • 5
    • 77956170550 scopus 로고    scopus 로고
    • New insights into apoptosis signaling by Apo2L/TRAIL
    • doi: 10.1038/onc.2010.221
    • Gonzalvez F, Ashkenazi A (2010) New insights into apoptosis signaling by Apo2L/TRAIL. Oncogene 29:4752-4765. doi: 10.1038/onc.2010.221
    • (2010) Oncogene , vol.29 , pp. 4752-4765
    • Gonzalvez, F.1    Ashkenazi, A.2
  • 6
    • 77956642345 scopus 로고    scopus 로고
    • Combining naturally occurring polyphenols with TNF-related apoptosis-inducing ligand: A promising approach to kill resistant cancer cells?
    • doi:10.1007/s00018-010-0407-6
    • Jacquemin G, Shirley S, Micheau O (2010) Combining naturally occurring polyphenols with TNF-related apoptosis-inducing ligand: a promising approach to kill resistant cancer cells? Cell Mol Life Sci 67:3115-3130. doi:10.1007/s00018-010-0407-6
    • (2010) Cell Mol Life Sci , vol.67 , pp. 3115-3130
    • Jacquemin, G.1    Shirley, S.2    Micheau, O.3
  • 7
    • 14644437742 scopus 로고    scopus 로고
    • Mechanisms of resistance to TRAIL-induced apoptosis in cancer
    • DOI 10.1038/sj.cgt.7700792
    • Zhang L, Fang B (2005) Mechanisms of resistance to TRAILinduced apoptosis in cancer. Cancer Gene Ther 12:228-237. doi: 10.1038/sj.cgt.7700792 (Pubitemid 40315182)
    • (2005) Cancer Gene Therapy , vol.12 , Issue.3 , pp. 228-237
    • Zhang, L.1    Fang, B.2
  • 8
    • 77649190268 scopus 로고    scopus 로고
    • TRAILing death in cancer
    • doi:10.1016/j.mam.2009. 12.002
    • MellierG,Huang S, Shenoy K, Pervaiz S (2010) TRAILing death in cancer. Mol Aspects Med 31:93-112. doi:10.1016/j.mam.2009. 12.002
    • (2010) Mol Aspects Med , vol.31 , pp. 93-112
    • Mellierghuang, S.1    Shenoy, K.2    Pervaiz, S.3
  • 9
    • 67649122040 scopus 로고    scopus 로고
    • Differential induction of apoptosis by apple procyanidins in TRAIL-sensitive human colon tumor cells and derived TRAIL-resistant metastatic cells
    • Maldonado-Celis ME, Bousserouel S, Gossé F, Minker C, Lobstein A, Raul F (2009) Differential induction of apoptosis by apple procyanidins in TRAIL-sensitive human colon tumor cells and derived TRAIL-resistant metastatic cells. J Cancer Mol 5:21-30. http://www.mupnet.com/JOCM%205(1)%2021.htm
    • (2009) J Cancer Mol , vol.5 , pp. 21-30
    • Maldonado-Celis, M.E.1    Bousserouel, S.2    Gossé, F.3    Minker, C.4    Lobstein, A.5    Raul, F.6
  • 10
    • 70350336226 scopus 로고    scopus 로고
    • Molecular crosstalk between TRAIL and natural antioxidants in the treatment of cancer
    • doi:10.1111/j.1476-5381.2009. 00266.x
    • Rushworth SA, Micheau O (2009) Molecular crosstalk between TRAIL and natural antioxidants in the treatment of cancer. Br J Pharmacol 157:1186-1188. doi:10.1111/j.1476-5381.2009. 00266.x
    • (2009) Br J Pharmacol , vol.157 , pp. 1186-1188
    • Rushworth, S.A.1    Micheau, O.2
  • 11
    • 42749092258 scopus 로고    scopus 로고
    • TRAIL receptortargeted therapeutics: Resistance mechanisms and strategies to avoid them
    • doi:10.1016/j.drup. 2008.02.001
    • Thorburn A, Behbakht K, Ford H (2008) TRAIL receptortargeted therapeutics: resistance mechanisms and strategies to avoid them. Drug Resist Updat 11:17-24. doi:10.1016/j.drup. 2008.02.001
    • (2008) Drug Resist Updat , vol.11 , pp. 17-24
    • Thorburn, A.1    Behbakht, K.2    Ford, H.3
  • 12
    • 33847265733 scopus 로고    scopus 로고
    • Silybin and silymarin: New and emerging applications in medicine
    • Gazák R, Walterová D, Kren V (2007) Silybin and silymarin: new and emerging applications in medicine. Curr Med Chem 14:315-338
    • (2007) Curr Med Chem , vol.14 , pp. 315-338
    • Gazák, R.1    Walterová, D.2    Kren, V.3
  • 13
    • 84928068169 scopus 로고    scopus 로고
    • Toxicology and carcinogenesis studies of milk thistle extract (CAS No. 84604-20-6) in F344/N rats and B6C3F1 mice (Feed Studies)
    • (2011) Toxicology and carcinogenesis studies of milk thistle extract (CAS No. 84604-20-6) in F344/N rats and B6C3F1 mice (Feed Studies). Natl Toxicol Program Tech Rep Ser 1-177
    • (2011) Natl Toxicol Program Tech Rep ser , pp. 1-177
  • 14
    • 27644439523 scopus 로고    scopus 로고
    • Mechanisms and preclinical efficacy of silibinin in preventing skin cancer
    • DOI 10.1016/j.ejca.2005.03.033
    • SinghRP,AgarwalR (2005)Mechanisms and preclinical efficacy of silibinin in preventing skin cancer. Eur J Cancer 41:1969-1979. doi: 10.1016/j.ejca.2005. 03.033 (Pubitemid 41557682)
    • (2005) European Journal of Cancer , vol.41 , Issue.13 , pp. 1969-1979
    • Singh, R.P.1    Agarwal, R.2
  • 15
    • 33745002041 scopus 로고    scopus 로고
    • Prostate cancer chemoprevention by silibinin: Bench to bedside
    • DOI 10.1002/mc.20223
    • Singh RP, Agarwal R (2006) Prostate cancer chemoprevention by silibinin: bench to bedside. Mol Carcinog 45:436-442. doi: 10.1002/mc.20223 (Pubitemid 43865852)
    • (2006) Molecular Carcinogenesis , vol.45 , Issue.6 , pp. 436-442
    • Singh, R.P.1    Agarwal, R.2
  • 16
    • 62349117597 scopus 로고    scopus 로고
    • Growth inhibition and regression of lung tumors by silibinin: Modulation of angiogenesis by macrophageassociated cytokines and nuclear factor-kappaB and signal transducers and activators of transcription 3
    • doi:10.1158/1940-6207.CAPR-08-0095
    • Tyagi A et al (2009) Growth inhibition and regression of lung tumors by silibinin: modulation of angiogenesis by macrophageassociated cytokines and nuclear factor-kappaB and signal transducers and activators of transcription 3. Cancer Prev Res (Phila) 2:74-83. doi:10.1158/1940-6207.CAPR-08-0095
    • (2009) Cancer Prev Res (Phila) , vol.2 , pp. 74-83
    • Tyagi, A.1
  • 17
    • 82955187812 scopus 로고    scopus 로고
    • Silibinin triggers apoptotic signaling pathways and autophagic survival response in human colon adenocarcinoma cells and their derived metastatic cells
    • doi:10.1007/s10495-011-0631-z
    • Kauntz H, Bousserouel S, Gossé F, Raul F (2011) Silibinin triggers apoptotic signaling pathways and autophagic survival response in human colon adenocarcinoma cells and their derived metastatic cells. Apoptosis 16:1042-1053. doi:10.1007/s10495-011-0631-z
    • (2011) Apoptosis , vol.16 , pp. 1042-1053
    • Kauntz, H.1    Bousserouel, S.2    Gossé, F.3    Raul, F.4
  • 18
    • 77957355392 scopus 로고    scopus 로고
    • Silibinin exerts sustained growth suppressive effect against human colon carcinoma SW480 xenograft by targeting multiple signaling molecules
    • doi:10.1007/s11095-010-0207-6
    • Velmurugan B et al (2010) Silibinin exerts sustained growth suppressive effect against human colon carcinoma SW480 xenograft by targeting multiple signaling molecules. Pharm Res 27:2085-2097. doi:10.1007/s11095-010-0207-6
    • (2010) Pharm Res , vol.27 , pp. 2085-2097
    • Velmurugan, B.1
  • 19
    • 62449168519 scopus 로고    scopus 로고
    • TRAIL agonists on clinical trials for cancer therapy: The promises and the challenges
    • Bellail AC, Qi L, Mulligan P, Chhabra V, Hao C (2009) TRAIL agonists on clinical trials for cancer therapy: the promises and the challenges. Rev Recent Clin Trials 4:34-41
    • (2009) Rev Recent Clin Trials , vol.4 , pp. 34-41
    • Bellail, A.C.1    Qi, L.2    Mulligan, P.3    Chhabra, V.4    Hao, C.5
  • 21
    • 34548590339 scopus 로고    scopus 로고
    • Silibinin sensitizes human glioma cells to TRAIL-mediated apoptosis via DR5 up-regulation and down-regulation of c-FLIP and survivin
    • DOI 10.1158/0008-5472.CAN-07-0407
    • Son Y-G et al (2007) Silibinin sensitizes human glioma cells to TRAIL-mediated apoptosis via DR5 up-regulation and downregulation of c-FLIP and survivin. Cancer Res 67:8274-8284. doi:10.1158/0008-5472.CAN-07-0407 (Pubitemid 47395165)
    • (2007) Cancer Research , vol.67 , Issue.17 , pp. 8274-8284
    • Son, Y.-G.1    Eun, H.K.2    Jin, Y.K.3    Kim, S.U.4    Taeg, K.K.5    Yoon, A.-R.6    Yun, C.-O.7    Kyeong, S.C.8
  • 22
    • 0033664012 scopus 로고    scopus 로고
    • Validation of a model of colon cancer progression
    • doi:10.1002/1096-9896(2000) 9999:9999\:AID-PATH775[3.0.CO;2-K
    • Hewitt RE et al (2000) Validation of a model of colon cancer progression. J Pathol 192:446-454. doi:10.1002/1096-9896(2000) 9999:9999\:AID-PATH775[3.0. CO;2-K
    • (2000) J Pathol , vol.192 , pp. 446-454
    • Hewitt, R.E.1
  • 23
    • 0035710746 scopus 로고    scopus 로고
    • -deltadeltaC T method
    • DOI 10.1006/meth.2001.1262
    • Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402-408. doi:10.1006/meth.2001.1262 (Pubitemid 34164012)
    • (2001) Methods , vol.25 , Issue.4 , pp. 402-408
    • Livak, K.J.1    Schmittgen, T.D.2
  • 24
    • 0032919099 scopus 로고    scopus 로고
    • Accurate flow cytometric membrane potential measurement in bacteria using diethyloxacarbocyanine and a ratiometric technique
    • DOI 10.1002/(SICI)1097-0320(19990101)35:1<55::AID-CYTO8>3.0.CO;2-2
    • Novo D, Perlmutter NG, Hunt RH, Shapiro HM (1999) Accurate flow cytometric membrane potential measurement in bacteria using diethyloxacarbocyanine and a ratiometric technique. Cytometry 35:55-63 (Pubitemid 29031192)
    • (1999) Cytometry , vol.35 , Issue.1 , pp. 55-63
    • Novo, D.1    Perlmutter, N.G.2    Hunt, R.H.3    Shapiro, H.M.4
  • 26
    • 34347215518 scopus 로고    scopus 로고
    • Analysis of apoptosis by propidium iodide staining and flow cytometry
    • doi: 10.1038/nprot.2006.238
    • Riccardi C, Nicoletti I (2006) Analysis of apoptosis by propidium iodide staining and flow cytometry. Nat Protoc 1:1458-1461. doi: 10.1038/nprot.2006.238
    • (2006) Nat Protoc , vol.1 , pp. 1458-1461
    • Riccardi, C.1    Nicoletti, I.2
  • 27
    • 79958186707 scopus 로고    scopus 로고
    • Off-target lapatinib activity sensitizes colon cancer cells through TRAIL death receptor up-regulation
    • doi:10.1126/scitranslmed.3001384
    • Dolloff NG et al. (2011) Off-target lapatinib activity sensitizes colon cancer cells through TRAIL death receptor up-regulation. Sci Transl Med 3:86ra50. doi:10.1126/scitranslmed.3001384
    • (2011) Sci Transl Med , vol.3
    • Dolloff, N.G.1
  • 29
    • 79952284127 scopus 로고    scopus 로고
    • Hallmarks of cancer: The next generation
    • doi:10.1016/j.cell.2011.02.013
    • Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646-674. doi:10.1016/j.cell.2011.02.013
    • (2011) Cell , vol.144 , pp. 646-674
    • Hanahan, D.1    Weinberg, R.A.2
  • 30
    • 28544443984 scopus 로고    scopus 로고
    • Promoting apoptosis as a strategy for cancer drug discovery
    • DOI 10.1038/nrc1736
    • Fesik SW (2005) Promoting apoptosis as a strategy for cancer drug discovery. Nat Rev Cancer 5:876-885. doi:10.1038/nrc1736 (Pubitemid 41746032)
    • (2005) Nature Reviews Cancer , vol.5 , Issue.11 , pp. 876-885
    • Fesik, S.W.1
  • 31
    • 77957965210 scopus 로고    scopus 로고
    • TRAIL: A sword for killing tumors
    • Wang S (2010) TRAIL: a sword for killing tumors. Curr Med Chem 17:3309-3317
    • (2010) Curr Med Chem , vol.17 , pp. 3309-3317
    • Wang, S.1
  • 33
    • 0344827261 scopus 로고    scopus 로고
    • Silibinin upregulates the expression of cyclin-dependent kinase inhibitors and causes cell cycle arrest and apoptosis in human colon carcinoma HT-29 cells
    • DOI 10.1038/sj.onc.1207158
    • Agarwal C et al (2003) Silibinin upregulates the expression of cyclin-dependent kinase inhibitors and causes cell cycle arrest and apoptosis in human colon carcinoma HT-29 cells. Oncogene 22:8271-8282. doi:10.1038/sj.onc. 1207158 (Pubitemid 37485520)
    • (2003) Oncogene , vol.22 , Issue.51 , pp. 8271-8282
    • Agarwal, C.1    Singh, R.P.2    Dhanalakshmi, S.3    Tyagi, A.K.4    Tecklenburg, M.5    Sclafani, R.A.6    Agarwal, R.7
  • 34
    • 33646739493 scopus 로고    scopus 로고
    • Pilot study of oral silibinin, a putative chemopreventive agent, in colorectal cancer patients: Silibinin levels in plasma, colorectum, and liver and their pharmacodynamic consequences
    • doi:10.1158/ 1078-0432.CCR-05-2724
    • Hoh C et al (2006) Pilot study of oral silibinin, a putative chemopreventive agent, in colorectal cancer patients: silibinin levels in plasma, colorectum, and liver and their pharmacodynamic consequences. Clin Cancer Res 12:2944-2950. doi:10.1158/ 1078-0432.CCR-05-2724
    • (2006) Clin Cancer Res , vol.12 , pp. 2944-2950
    • Hoh, C.1
  • 35
    • 59549107896 scopus 로고    scopus 로고
    • Silibinin inhibits hypoxiainducible factor-1alpha and mTOR/p70S6K/4E-BP1 signalling pathway in human cervical and hepatoma cancer cells: Implications for anticancer therapy
    • doi:10.1038/ onc.2008.398
    • Garc?́a-Maceira P, Mateo J (2009) Silibinin inhibits hypoxiainducible factor-1alpha and mTOR/p70S6K/4E-BP1 signalling pathway in human cervical and hepatoma cancer cells: implications for anticancer therapy. Oncogene 28:313-324. doi:10.1038/ onc.2008.398
    • (2009) Oncogene , vol.28 , pp. 313-324
    • Garća-Maceira, P.1    Mateo, J.2
  • 36
    • 67349224064 scopus 로고    scopus 로고
    • Overexpression of Reticulon 3 (RTN3) enhances TRAIL-mediated apoptosis via up-regulation of death receptor 5 (DR5) and down-regulation of c-FLIP
    • doi:10.1016/j.canlet. 2009.01.035
    • Lee JT, Lee T-J, Kim C-H, Kim N-S, Kwon TK (2009) Overexpression of Reticulon 3 (RTN3) enhances TRAIL-mediated apoptosis via up-regulation of death receptor 5 (DR5) and down-regulation of c-FLIP. Cancer Lett 279:185-192. doi:10.1016/j.canlet. 2009.01.035
    • (2009) Cancer Lett , vol.279 , pp. 185-192
    • Lee, J.T.1    Lee, T.-J.2    Kim, C.-H.3    Kim, N.-S.4    Kwon, T.K.5
  • 37
    • 12544255082 scopus 로고    scopus 로고
    • Receptor-selective mutants of apoptosisinducing ligand 2/tumor necrosis factor-related apoptosis-inducing ligand reveal a greater contribution of death receptor (DR) 5 than DR4 to apoptosis signaling
    • doi:10.1074/jbc.M410660200
    • Kelley RF et al (2005) Receptor-selective mutants of apoptosisinducing ligand 2/tumor necrosis factor-related apoptosis-inducing ligand reveal a greater contribution of death receptor (DR) 5 than DR4 to apoptosis signaling. J Biol Chem 280:2205-2212. doi:10.1074/jbc.M410660200
    • (2005) J Biol Chem , vol.280 , pp. 2205-2212
    • Kelley, R.F.1
  • 38
    • 33646574281 scopus 로고    scopus 로고
    • The dietary flavonoid apigenin sensitizes malignant tumor cells to tumor necrosis factor-related apoptosis-inducing ligand
    • DOI 10.1158/1535-7163.MCT-05-0431
    • Horinaka M et al (2006) The dietary flavonoid apigenin sensitizes malignant tumor cells to tumor necrosis factor-related apoptosisinducing ligand. Mol Cancer Ther 5:945-951. doi:10.1158/ 1535-7163.MCT-05-0431 (Pubitemid 43724594)
    • (2006) Molecular Cancer Therapeutics , vol.5 , Issue.4 , pp. 945-951
    • Horinaka, M.1    Yoshida, T.2    Shiraishi, T.3    Nakata, S.4    Wakada, M.5    Sakai, T.6
  • 41
    • 0033974084 scopus 로고    scopus 로고
    • Molecular determinants of response to TRAIL in killing of normal and cancer cells
    • Kim K, Fisher MJ, Xu SQ, el-Deiry WS (2000) Molecular determinants of response to TRAIL in killing of normal and cancer cells. Clin Cancer Res 6:335-346 (Pubitemid 30111448)
    • (2000) Clinical Cancer Research , vol.6 , Issue.2 , pp. 335-346
    • Kim, K.1    Fisher, M.J.2    Xu, S.-Q.3    El-Deiry, W.S.4
  • 43
    • 33746886979 scopus 로고    scopus 로고
    • Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy
    • DOI 10.1038/sj.onc.1209608, PII 1209608
    • Fulda S, Debatin K-M (2006) Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene 25:4798-4811. doi:10.1038/sj.onc.1209608 (Pubitemid 44187627)
    • (2006) Oncogene , vol.25 , Issue.34 , pp. 4798-4811
    • Fulda, S.1    Debatin, K.-M.2
  • 44
    • 42049116091 scopus 로고    scopus 로고
    • Mcl-1: A gateway to TRAIL sensitization
    • DOI 10.1158/0008-5472.CAN-07-6278
    • Kim S-H, Ricci MS, El-Deiry WS (2008) Mcl-1: a gateway to TRAIL sensitization. Cancer Res 68:2062-2064. doi:10.1158/ 0008-5472.CAN-07-6278 (Pubitemid 351521775)
    • (2008) Cancer Research , vol.68 , Issue.7 , pp. 2062-2064
    • Kim, S.-H.1    Ricci, M.S.2    El-Deiry, W.S.3
  • 46
    • 34250862069 scopus 로고    scopus 로고
    • Expression of anti-apoptotic factors modulates Apo2L/TRAIL resistance in colon carcinoma cells
    • DOI 10.1007/s10495-007-0076-6
    • Lippa MS et al (2007) Expression of anti-apoptotic factors modulates Apo2L/TRAIL resistance in colon carcinoma cells. Apoptosis 12:1465-1478. doi:10.1007/s10495-007-0076-6 (Pubitemid 46988283)
    • (2007) Apoptosis , vol.12 , Issue.8 , pp. 1465-1478
    • Lippa, M.S.1    Strockbine, L.D.2    Le, T.T.3    Branstetter, D.G.4    Strathdee, C.A.5    Holland, P.M.6
  • 47
    • 2342615480 scopus 로고    scopus 로고
    • X-Linked Inhibitor of Apoptosis Protein (XIAP) Is a Nonredundant Modulator of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL)-Mediated Apoptosis in Human Cancer Cells
    • DOI 10.1158/0008-5472.CAN-04-0046
    • Cummins JM et al (2004) X-linked inhibitor of apoptosis protein (XIAP) is a nonredundant modulator of tumor necrosis factorrelated apoptosis-inducing ligand (TRAIL)-mediated apoptosis in human cancer cells. Cancer Res 64:3006-3008 (Pubitemid 38581397)
    • (2004) Cancer Research , vol.64 , Issue.9 , pp. 3006-3008
    • Cummins, J.M.1    Kohli, M.2    Rago, C.3    Kinzler, K.W.4    Vogelstein, B.5    Bunz, F.6
  • 48
    • 53649109665 scopus 로고    scopus 로고
    • A mitochondrial block and expression of XIAP lead to resistance to TRAIL-induced apoptosis during progression to metastasis of a colon carcinoma
    • doi:10.1038/onc.2008.197
    • Ndozangue-Touriguine O et al (2008) A mitochondrial block and expression of XIAP lead to resistance to TRAIL-induced apoptosis during progression to metastasis of a colon carcinoma. Oncogene 27:6012-6022. doi:10.1038/onc.2008.197
    • (2008) Oncogene , vol.27 , pp. 6012-6022
    • Ndozangue-Touriguine, O.1
  • 49
    • 61349193762 scopus 로고    scopus 로고
    • Ceramide synthase 6 modulates TRAIL sensitivity and nuclear translocation of active caspase-3 in colon cancer cells
    • doi:10.1038/ onc.2008.468
    • White-Gilbertson S et al (2009) Ceramide synthase 6 modulates TRAIL sensitivity and nuclear translocation of active caspase-3 in colon cancer cells. Oncogene 28:1132-1141. doi:10.1038/ onc.2008.468
    • (2009) Oncogene , vol.28 , pp. 1132-1141
    • White-Gilbertson, S.1
  • 51
    • 4143115887 scopus 로고    scopus 로고
    • Deficient tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) death receptor transport to the cell surface in human colon cancer cells selected for resistance to TRAIL-induced apoptosis
    • DOI 10.1074/jbc.M405538200
    • Jin Z, McDonald ER, Dicker DT, El-Deiry WS (2004) Deficient tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) death receptor transport to the cell surface in human colon cancer cells selected for resistance to TRAIL-induced apoptosis. J Biol Chem 279:35829-35839. doi:10.1074/jbc.M405538200 (Pubitemid 39100590)
    • (2004) Journal of Biological Chemistry , vol.279 , Issue.34 , pp. 35829-35839
    • Jin, Z.1    McDonald III, E.R.2    Dicker, D.T.3    El-Deiry, W.S.4
  • 52
    • 0029888514 scopus 로고    scopus 로고
    • Biological and clinical importance of the p53 tumor suppressor gene
    • Velculescu VE, El-Deiry WS (1996) Biological and clinical importance of the p53 tumor suppressor gene. Clin Chem 42:858-868
    • (1996) Clin Chem , vol.42 , pp. 858-868
    • Velculescu, V.E.1    El-Deiry, W.S.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.